Lavelle Erin
- SEC CIK
- 0001737613
No open-market purchases or sales filed in the past year.
Current role at each company
- JBIO Jade Biosciences, Inc.Directoras of Jun 11, 2026
- AVLN Avalyn Pharma Inc.Directoras of May 1, 2026
- NGNE Neurogene Inc.Directoras of Jun 9, 2023
- CLYM Climb Bio, Inc.COO & CFOas of Nov 2, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lavelle Erin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
No insider trades match these filters.